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Background. Rickets was first described in the 17th century and vitamin D deficiency was recognized as the
underlying cause in the early 1900s. Despite this long history, vitamin D deficiency remains a significant
health concern. Currently, vitamin D supplementation is recommended in Canada for breast fed infants.
There are no recommendations for supplementation in formula-fed infants.
Objective. The objective of this report is to bring attention to the risk of severe vitamin D deficiency in high
risk, formula fed infants.
Design. A retrospective chart review was used to create this clinical case series.
Results. Severe vitamin D deficiency was diagnosed in six formula-fed infants over a two-and-a-half year
period. All six infants presentedwith seizures and they resided in First Nation communities located at latitude
54 in the province of Manitoba. While these infants had several risk factors for vitamin D deficiency, they
were all receiving cow’s milk based formula supplemented with 400 IU/L of vitamin D.
Conclusion. This report suggests that current practice with regards to vitamin D supplementation may be
inadequate, especially for high-risk infants. Health care professionals providing service to infants in a similar
situation should be aware of this preventable condition. Hopefully this would contribute to its prevention,
diagnosis and management.
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R
ickets was first described in the 17th century
by Dr. Daniel Whistler and Professor Francis
Glisson (1). However, it was not until the early
1900s that vitamin D deficiency was recognised as the
underlying cause, and that the importance of sunlight
to maintain adequate vitamin D levels was appreciated.
Vitamin D fortification of food began in an attempt to
address this widespread deficiency and ensure adequate
intake. In Canada, the fortification of evaporated and
dried milks began in 1950, while in 1965 the regulations
were changed to include fluid milk (2). Infant formula is
also fortified with 400 IU/L (3).
Despite the long history of recognition of this problem,
vitamin D deficiency continues to remain a significant
health issue (412). The incidence of vitamin D deficiency
in Canada is not known. The Canadian Paediatric
Surveillance Program (CPSP) recently included vitamin
D deficiency rickets in its national surveillance program
(13). One-hundred-and-four cases of vitamin D deficiency
rickets were reported over a 2-year period in infants
and toddlers, 96.2% of whom had been breast-fed. 86.5%
of these infants had not received vitamin D supple-
mentation. Three cases were formula-fed, 2 of which are
included in this report along with 4 others.
From May 2003 to March 2005, we diagnosed vitamin
D deficiency in 6 exclusively formula-fed First Nation
infants presenting with hypocalcaemic seizures. Approval
for submission of this report was received from the
Human Research Ethics Board, Faculty of Medicine,
University of Manitoba.
Cases
Theclinicalinformationofthe6casesispresentedinTable
I. Age at presentation varied from 5 days to 7 weeks. All 6
infantswere of First Nation descent, full term, and had no
significant medical history. All were from isolated First
Nations communities  400 km northeast of Winnipeg
(approximately the 54th parallel of latitude). They wereall
exclusively fed a vitamin D fortified cow’s milk-based
infant formula and were gaining weight appropriately.
Proper formula preparation was verified. All 6 infants
presented with seizures, either focal or generalised.
The profiles of the cases at presentation are sum-
marised in Table I. The parathyroid hormone (PTH) level
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D levelwaslow in allinfants. The 25-vitamin D levelswere
available in the mothers of infant No. 2 and 3 and both
were deficient (16 nmol/L and B15 nmol/L respectively;
normal 75200 nmol/L). Of the 2 mothers with recorded
data, consumption of milk was minimal. None of the
mothers were taking prenatal supplements.
Once therapy was initiated, none of the infants had
recurrence of seizures. Cases 1, 2, 4, and 6 were initially
treated with calcitriol, vitamin D3 supplements (2000 IU/
day) (cholecalciferol), and oral calcium supplements.
Calcitriol was discontinued after 2 weeks. Cases 3 and
5 were treated with cholecalciferol and calcium supple-
ments in hospital and then discharged home on vitamin
D 2000 IU/day. Vitamin D3 (2000 IU/day) was continued
in all 6 infants for 2 months and then decreased to 400
IU/day.
Discussion
Within a relatively short time period, we have seen 6 cases
of severe vitamin D deficiency presenting with hypocal-
caemic seizures in formula-fed First Nation infants less
than 2 months of age. All had multiple risk factors for
vitamin D deficiency including darker skin pigmentation,
limited cutaneous sun exposure, residence at a northern
latitude of 548, and confirmed or suspected vitamin D
deficiency in their mothers. All presented in the late
autumn, winter or early spring when cutaneous synthesis
of vitamin D would be minimal. In the 2 youngest infants
in our series, it is likely that profound maternal vitamin D
deficiency was the most significant factor leading to the
early presentation of these infants.
The PTH level in the youngest infant in this series was
not elevated in response to hypocalcaemia (PTH 16 ng/
L). This may represent the physiologic blunting of PTH
response in the newborn period (14). Case 1 had a family
history of seizures, and may have had a lower seizure
threshold, possibly explaining why this infant presented
with seizures when the ionised calcium was 0.97 mmol/L.
The infants in this series were exclusively bottle fed
a cow’s milk-based formula fortified with 400 IU/L of
vitamin D. They differ from the infants with vitamin D
deficiency in the CPSP study, 96.2% of whom were breast
fed (13). The infants in our report were also significantly
younger than those from the CPSP study. In the CPSP
study, 34 out of 104 children with vitamin D deficiency
presented under 1 year of age. Of these infants, mean
age at presentation was 0.6 years. It is likely that the
younger age of presentation in our series reflects more
profound deficiency and very likely severe maternal
deficiency.
There havebeen several recent reports of severe vitamin
D deficiency presenting with hypocalcaemic seizures in
breast fed infants. In general, these infants were older at
presentation when maternally derived stores would be
expected to be depleted (1519). Vitamin D deficiency
presenting as hypocalcaemic seizures has also been
reported in 3 infants fed soy-based infant formula (20).
A series of infants (B13 months of age) presenting
with hypocalcaemic seizures was previously reported by
investigators at the Winnipeg Children’s Hospital Health
Sciences Centre in Manitoba almost 4 decades ago. These
infants were presumed to be vitamin D deficient though
Table I. Clinical presentation and serum biochemistry proﬁles at presentation of 6 conﬁrmed cases of severe vitamin D deﬁciency
Case
Age at
diagnosis (day) Presentation
Calcium (mmol/L);
total/ionised
Phosphate
(mmol/L)
ALP
(IU/L)
PTH
(ng/L)
25-Vitamin
D (nmol/L) Gender
Month of
presentation
Maternal
25-vitamin D
(nmol/L)
1 49 Focal
seizures
1.54/0.97 2.23 675 266 B15 Male March N/A
2 6 Focal to
generalised
seizures
1.47/0.95 3.55 435 52 25 Female January 16
3 5 Generalised
seizures
1.35/na 3.29 310 16 16 Male June B15
4 42 Focal
seizures
1.57/0.99* 3.2 632 73 B15 Male November N/A
5 42 Generalised
seizures
1.55/na 1.87 586 175 B15 Female January N/A
6 35 Focal
seizures
1.52/0.84 2.81 573 184 B15 Female May N/A
ALPalkaline phosphatase, PTHparathyroid hormone.
*Ionised calcium was drawn 2 hours after patient received bolus of IV calcium.
Normal values: Total calcium (2.102.60 mmol/L); ionised calcium ( 1.0 mmol/L); phosphate (1.282.26 mmol/L); ALP (117352 IU/L);
PTH (750 ng/L), 25-vitamin D (75200 nmol/L).
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report does not detail the infant feeding practices (21).
The current statement put forth by the Canadian
Paediatric Society, Dieticians of Canada, and Health
Canada on nutrition for term infants recommends
supplementing with 400 IU/day of vitamin D only for
breast fed infants (22). There is no recommendation for
supplementation in formula-fed babies. In an attempt to
address the concerning frequency of vitamin D deficiency
in Aboriginal infants, the Canadian Paediatric Society
advocates for an increase to 800 IU/day in northern
native communities during the winter months (23). The
Canadian Paediatric Society statement does not clearly
differentiate breast-fed vs. formula-fed infants but does
suggest that infant formulas should be an adequate source
of vitamin D as long as the infant consumes ‘‘adequate
quantity’’ (23). It seems unlikely that infants in the first
few months of life would drink 2 L of formula/day, the
volume necessary to receive 800 IU/day of vitamin D.
Four of our cases presented during the autumn and
winter months, the other two infants presented during
the early spring. None of these infantswere receiving daily
vitamin D supplementation. The American Academy of
Paediatrics now recommends that formula-fed newborns
who do not consume a minimum of 1 litre of formula per
day receive supplementation to achieve an intake of 400
IU vitamin D/day (24). A recent telephone survey of
mothers of full-term infants in Montreal identified that
infants consuming mixed feedings (breast and formula)
and those exclusively formula-fed were at high risk of
not meeting recommended vitamin D intake in the first
6 months of life (25).
Transplacental transfer of vitamin D stores from
the mother to foetus occur during the third trimester.
Adequate transfer of stores depends on the vitamin D
status of the mother. In infants born to a vitamin-
D-replete mother, these stores are exhausted by approxi-
mately 8 weeks of age (26). Maternal vitamin D deficiency
remains a common concern (27). In the mothers of the
infants presented in this report milk consumption was
minimal and none were taking prenatal vitamins. They
were also all living at northern latitude and had darker
skin pigment. These factors contribute to vitamin D
deficiency in the mothers, and therefore, poor placental
transfer to the infant (28). In addition, Aboriginal women
from Manitoba have been shown to have lower vitamin
D levels than Caucasian women even though vitamin
D intake did not differ between the groups. In this study,
 30% of Aboriginal women had vitamin D levels B37.5
nmol/L compared to 18.6% of Caucasian women (29).
Vitamin D levels were deficient in both the mothers
in this report who had levels drawn. Given the young
age of the cases presented (mean age 30 days), maternal
vitamin D deficiency is likely a major contributing factor
in all the cases presented. The reason for poor use of
prenatal vitamins in this population is not clear. While the
mothers reside in remote First Nations communities,
access to prenatal care is local and prenatal supplements
are available at no cost to the individual.
Vitamin D deficiency continues to remain a significant
health issue in Canadian northern communities. While
our 6 infants had numerous risk factors for vitamin D
deficiency, they were not breast fed, which was the most
consistent finding in previous reports (13, 1519). The
infants we report presented with hypocalcaemic seizures
and represent the most severe spectrum of the problem.
It is likely that other asymptomatic infants with vitamin
D deficiency remain undiagnosed from this high-risk
population. This raises the question of whether 400 IU of
vitamin D per litre of formula is sufficient. Policies have
been put forth to address this issue in the high risk First
Nation and Inuit populations; however, in our experience,
they are either not being implemented and/or compli-
ance remains a barrier. This underlies the importance of
awareness among primary care providers.
Conclusion
We suggest that the amount of vitamin D supplementa-
tion needed to prevent deficiency in infants residing in
communities in the temperate region should be revisited,
particularly for those at high risk for prenatal deficiency.
Attention also needs to be focused on the prevention
of maternal vitamin D deficiency. In addition, education
and other strategies are needed to ensure that current and
new policies are effectively implemented.
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